Related Experiment Videos
Newborn screening for sickle cell disease. When is an infant 'lost to follow-up'?
S T Miller1, T V Stilerman, S P Rao
1Department of Pediatrics, State University of New York-Children's Medical Center of Brooklyn.
Insights
Timely follow-up is crucial for newborn screening programs for sickle cell disease. Early education and penicillin therapy can prevent serious complications, but parental contact for care initiation can be challenging in urban settings.
Area of Science:
- Medical research
- Pediatrics
- Genetics
Background:
- Newborn screening for sickle cell disease (SCD) is vital for early intervention.
- Timely follow-up care, including education on fever and splenic palpation, and prophylactic penicillin therapy, is essential to reduce morbidity and mortality.
- Initiation of care before 4 months of age is recommended.
Purpose of the Study:
- To highlight the challenges in contacting parents for follow-up care in urban populations.
- To emphasize the medical and legal obligations of healthcare providers in managing newborns with SCD.
- To underscore the importance of preventing adverse outcomes in infants with missed diagnoses.
Main Methods:
- Review of outcomes for infants identified with sickle cell disease.
- Analysis of parental contact success rates for initial appointments.
- Discussion of medical and legal responsibilities.
Main Results:
- Only 36% (9 of 25) of infants identified with SCD attended their initial appointments.
- Parental contact for care implementation poses significant difficulties, especially in large urban settings.
- A substantial number of infants may not receive timely, life-saving interventions.
Conclusions:
- Effective strategies are needed to improve parental engagement and follow-up for newborns with SCD.
- Healthcare providers must be vigilant about their responsibilities to prevent 'missed cases' and ensure optimal outcomes.
- Addressing barriers to care access is critical for the success of newborn screening programs for SCD.
Abstract:
Success of programs to screen newborns for sickle cell disease depends on timely follow-up. Education regarding fever and splenic palpation, and initiation of prophylactic penicillin therapy, will reduce morbidity and mortality and should occur prior to 4 months of age. However, contacting parents to permit implementation of care may be difficult, particularly in large urban populations; only nine (36%) of 25 infants recently identified as having sickle cell disease arrived at our institution for initial appointments. Medical providers must be aware of medical and legal obligations related to follow-up of newborns with sickle cell disease to prevent untoward events in "missed cases."